Does Green Brazilian Propolis Extract Improve Functional Capacity in Symptomatic Chronic Coronary Disease?—A Pilot Randomized Trial
<b>Background:</b> Inflammation plays a critical role in the progression of coronary heart disease (CHD). Low-dose colchicine has shown promise in reducing cardiovascular events, and green Brazilian propolis extract (EPP-AF® (standardized Brazilian green propolis extract) was provided by...
Saved in:
Main Authors: | Clara Salles Figueiredo, Luiz Carlos Santana Passos, Caio Rebouças Fonseca Cafezeiro, Rodrigo Morel Vieira de Melo, Tainá Teixeira Viana, Eduardo Jorge Gomes de Oliveira, Andresa Aparecida Berretta, Marcelo Augusto Duarte Silveira |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-05-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/18/6/827 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Propolis as a Treatment Option for Hand, Foot, and Mouth Disease (HFMD) in Children: A Prospective Randomized Clinical Study
by: Manolya Kara, et al.
Published: (2025-05-01) -
Antiviral Activity of Brazilian Propolis from Stingless Bees Against Rotavirus
by: Guadalupe González-Ochoa, et al.
Published: (2025-06-01) -
Patent-Based Technological Overview of Propolis–Cyclodextrin Inclusion Complexes with Pharmaceutical Potential
by: Salvana Costa, et al.
Published: (2025-07-01) -
Study on the effect of propolis extracted by ethanol or water on acute inflammation in animals based on model tests
by: HU Fu-liang, et al.
Published: (2003-07-01) -
Effects of propolis on diabetes mellitus in SD rats
by: HU Fu-liang, et al.
Published: (2004-03-01)